Saint Kitts and Nevis vs Saint Lucia: The number of people with susceptibility test result for rifampicin
Saint Kitts and Nevis
0
in 2021
Saint Lucia
2
in 2021
Saint Kitts and Nevis rank
146th
Saint Lucia rank
143rd
The number of people with susceptibility test result for rifampicin over time
- Saint Kitts and Nevis
- Saint Lucia
How they compare
Saint Lucia currently reports 2 against 0 in Saint Kitts and Nevis, a difference of 2.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Saint Lucia ahead.
Saint Kitts and Nevis ranks 146th and Saint Lucia ranks 143rd of 155 countries.
Saint Lucia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Saint Kitts and Nevis | Saint Lucia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1 | 5 | 4 | Saint Lucia |
| 2020s | 0.5 | 2.5 | 2 | Saint Lucia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Saint Kitts and Nevis or Saint Lucia?
- Saint Lucia, at 2 against 0 in Saint Kitts and Nevis as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Saint Kitts and Nevis and Saint Lucia?
- 2, with Saint Lucia ahead.
- How many years of comparable data are there for Saint Kitts and Nevis and Saint Lucia?
- 5 years are reported by both, from 2017 to 2021.
- How do Saint Kitts and Nevis and Saint Lucia rank globally for the number of people with susceptibility test result for rifampicin?
- Saint Kitts and Nevis ranks 146th and Saint Lucia ranks 143rd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.